Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Affiliation country
Publication year range
1.
Zhongguo Zhong Yao Za Zhi ; 40(15): 3047-52, 2015 Aug.
Article in Chinese | MEDLINE | ID: mdl-26677709

ABSTRACT

To verify the effect of echinacoside on replication and antigen expression of hepatitis B virus (HBV) by using HBV-transfected HepG2. 2. 15 cells as the in vitro model. The ELISA method was used to determine HBeAg and HBsAg levels in cellular supernatants. The effect of echinacoside on HBV replication was studied by using HBV transgenic mice as the in vivo model. First of all, the HBV DNA level in hepatic tissues was quantified with PCR method. Meanwhile, the serum transaminase levels and hepatic pathological changes were also evaluated. Subsequently, HBV transgenic mice were divided into five groups: the control group, the lamivudine group (50 mg · kg(-1)) and echinacoside high, medium and low dose group (50, 25 and 12.5 mg · kg(-1)). The mice were orally administered with drugs once per day for 30 days. At the 31st day, the mice serum was separated to measure HBsAg, HBeAg and HBV DNA. Additionally, the liver HBV DNA level and histopathological change were detected. The results indicated that echinacoside at 50 and 100 mg · L(-1) suppressed significantly HBsAg and HBeAg expressions on the sixth day, with the maximum inhibition ratios of 42.68% and 46.29%; And echinacoside at 100 mg · L(-1) also showed an inhibitory effect on HBV DNA. Besides, echinacoside at 50 mg · kg(-1) inhibited significantly HBsAg and HBeAg expressions of HBV transgenic mice, with the inhibition ratios of 42.82% and 29.12%, and reduced markedly the serum HBV DNA level in HBV transgenic mice. In conclusion, the study suggested that echinacoside has a strong effect against HBV replication and antigen expression.


Subject(s)
Glycosides/pharmacology , Hepatitis B virus/drug effects , Virus Replication/drug effects , Animals , DNA, Viral/blood , Female , Hep G2 Cells , Hepatitis B Surface Antigens/blood , Hepatitis B e Antigens/blood , Hepatitis B virus/physiology , Humans , Male , Mice , Mice, Inbred C57BL
2.
Biol Pharm Bull ; 38(3): 396-401, 2015.
Article in English | MEDLINE | ID: mdl-25560232

ABSTRACT

Micro-RNAs (miRNAs) are involved in regulation of the incidence and development of several hepatic diseases. Thus manipulating miRNAs may be a promising therapeutic strategy against these entities. In this study hepatic stellate cells (HSCs) were transfected with hsa-miR-9 or anti-hsa-miR-9, treated with tetramethylpyrazine (TMP), or subjected to treatment with TMP and hsa-miR-9 transfection (combined treatment group). Then, real-time polymerase chain reaction (PCR) was performed to measure mRNA levels of hsa-miR-9. Expression of hsa-miR-9 was highest in the combination treatment group compared with other groups, and significantly higher than TMP-treated and hsa-miR-9-transfected groups (both p<0.05). The anti-hsa-miR-9-transfected group expressed the lowest mRNA level of hsa-miR-9 with marked decrease versus control (p<0.05). Downstream factors that may be affected by miR-9 such as leptin, α-smooth muscle actin (SMA), and collagen I, as well as phosphorylation levels of Janus kinase 1 (JAK1)/signal transducer and activator of transcription 3 (STAT3) were investigated at the protein level. All these factors were regulated contrariwise to expression trends of hsa-miR-9, showing the lowest level in the combination treatment group and highest level in anti-hsa-miR-9-transfected group. These results suggest that both transfection of hsa-miR-9 and TMP can lead to upregulated endogenous expression of hsa-miR-9, inhibit activation of JAK1/STAT3 signal pathway induced by leptin, and lead to reduction of α-SMA and collagen I-thus impeding activation of HSC.


Subject(s)
Gene Expression Regulation , Hepatic Stellate Cells/drug effects , Leptin/metabolism , Liver Cirrhosis/metabolism , MicroRNAs/metabolism , Plant Extracts/pharmacology , Pyrazines/pharmacology , Actins/metabolism , Collagen Type I/metabolism , Hepatic Stellate Cells/metabolism , Humans , Janus Kinase 1/metabolism , Ligusticum/chemistry , Liver Cirrhosis/prevention & control , MicroRNAs/genetics , Phosphorylation , Phytotherapy , Plant Extracts/therapeutic use , Pyrazines/therapeutic use , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , STAT3 Transcription Factor/metabolism , Signal Transduction , Transfection , Up-Regulation
3.
J Ethnopharmacol ; 144(1): 190-4, 2012 Oct 31.
Article in English | MEDLINE | ID: mdl-22982394

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: The aim of this study was to determine the anti-hepatitis B effect of isochlorogenic acid A isolated from Laggera alata (Asteraceae), a traditional Chinese herbal medicine. MATERIALS AND METHODS: The anti-hepatitis B activity of isochlorogenic acid A was evaluated by the D-galactosamine (D-GalN)-induced HL-7702 hepatocyte damage model and the HBV-transfected HepG2.2.15 cells. RESULTS: Isochlorogenic acid A significantly improved HL-7702 hepatocyte viability and markedly inhibited the productions of HBsAg and HBeAg. The inhibitory rates of isochlorogenic acid A on the HBsAg and HBeAg expressions were 86.9% and 72.9%, respectively. In addition, isochlorogenic acid A declined markedly the content of hepatitis B virus covalently closed circular DNA (HBV cccDNA) and induced significantly the heme oxygenase-1 (HO-1) expression in HepG2.2.15 cells. CONCLUSIONS: Isochlorogenic acid A was verified to possess the potent anti-hepatitis B activity. The anti-HBV target of isochlorogenic acid A is probably associated with blocking the translation step of the HBV replication. Overexpression of HO-1 may contribute to the anti-HBV activity of isochlorogenic acid A by reducing the stability of the HBV core protein and thus blocking the refill of nuclear HBV cccDNA. Additionally, the hepatoprotective effect of isochlorogenic acid A could be achieved by its antioxidative property and induction of HO-1.


Subject(s)
Antiviral Agents/pharmacology , Asteraceae , Chlorogenic Acid/analogs & derivatives , Hepatitis B virus/drug effects , Protective Agents/pharmacology , Antigens, Viral/analysis , Cell Survival/drug effects , Chlorogenic Acid/pharmacology , DNA, Viral/analysis , Heme Oxygenase-1/metabolism , Hep G2 Cells , Hepatitis B/prevention & control , Hepatitis B virus/genetics , Humans
4.
Comp Biochem Physiol C Toxicol Pharmacol ; 150(4): 465-73, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19607933

ABSTRACT

Hsp90, a molecular chaperone, was generally thought to be a unique cytoplasmic form in invertebrates, playing important roles in multiple cellular stress responses. Now, two cytoplasmic Hsp90 cDNAs (ptHSP90-1 and ptHSP90-2 genes) were isolated from an invertebrate - crab Portunus trituberculatus. Main features, sequence identities and phylogenetic analysis with other species were described. Expression profiles in tissues and under stressful conditions were analyzed using semi-quantitative RT-PCR method. ptHSP90-1 and ptHSP90-2 were constitutively expressed with higher transcript levels in ovary and muscle, respectively. A cold treatment rapidly activated both ptHSP90s transcription in hepatopancreas and gill, but caused the ptHSP90-2 mRNA decrease in muscle and ovary. Under heat treatment ptHSP90-1 mRNA was accumulated in hepatopancreas and muscle (but down-regulated in ovary), while ptHSP90-2's transcription tendency in each tissue was the same as that in cold shock. Moreover, the transcriptional levels of both ptHSP90 genes under Cu(2+) stress were evaluated. This crab exposed to the low and high salinity exhibited either lower expression levels of both ptHSP90s or no changes in four tissues except the up-regulation of ptHSP90-2 transcription in hepatopancreas. These results suggested there were at least two Hsp90s in P. trituberculatus, which played differing roles in physiological and stressful conditions.


Subject(s)
Brachyura/genetics , Cold Temperature , Gene Expression Profiling , HSP90 Heat-Shock Proteins/genetics , Sodium Chloride/pharmacology , Stress, Physiological , Amino Acid Sequence , Animals , Base Sequence , Copper/metabolism , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Female , Hepatopancreas/metabolism , Isoelectric Point , Male , Molecular Sequence Data , Molecular Weight , Muscles/metabolism , Open Reading Frames , Ovary/metabolism , Phylogeny , Protein Sorting Signals , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Tissue Distribution , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL